DrugPatentWatch Database Preview
Patent: 8,883,146
» See Plans and Pricing
Summary for Patent: 8,883,146
| Title: | Protein formulations and methods of making same |
| Abstract: | The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality. |
| Inventor(s): | Fraunhofer; Wolfgang (Gurnee, IL), Bartl; Annika (Ludwigshafen, DE), Krause; Hans-Juergen (Biblis, DE), Tschoepe; Markus (Hessheim, DE), Kaleta; Katharina (Ludwigshafen, DE) |
| Assignee: | AbbVie Inc. (North Chicago, IL) |
| Application Number: | 13/774,735 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,883,146
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | HERCEPTIN HYLECTA | trastuzumab; hyaluronidase-oysk | INJECTABLE;SUBCUTANEOUS | 761106 | 001 | 2019-02-28 | Start Trial | AbbVie Inc. (North Chicago, IL) | 2027-11-30 | RX | search | |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 002 | 2017-06-22 | Start Trial | AbbVie Inc. (North Chicago, IL) | 2027-11-30 | RX | Orphan | search |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 001 | 2017-06-22 | Start Trial | AbbVie Inc. (North Chicago, IL) | 2027-11-30 | RX | Orphan | search |
| Wyeth Pharms Inc | MYLOTARG | gemtuzumab ozogamicin | VIAL;SINGLE-DOSE | 761060 | 001 | 2018-04-09 | Start Trial | AbbVie Inc. (North Chicago, IL) | 2027-11-30 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,883,146
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201205433 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2009073569 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2014130064 | Start Trial |
| United States of America | 2009291062 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
